Dr. Mustapha Abdul-Rahman, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,000 | 18 | 93.7% |
| Travel and Lodging | $877.68 | 5 | 3.6% |
| Food and Beverage | $660.53 | 29 | 2.7% |
| Education | $11.71 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $22,681 | 29 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $1,550 | 6 | $0 (2018) |
| Radius Health, Inc. | $49.54 | 1 | $0 (2024) |
| Abbott Laboratories | $41.45 | 2 | $0 (2023) |
| Medtronic, Inc. | $36.84 | 2 | $0 (2024) |
| Novo Nordisk Inc | $28.85 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $27.54 | 2 | $0 (2020) |
| Currax Pharmaceuticals LLC | $27.03 | 2 | $0 (2022) |
| Lilly USA, LLC | $23.87 | 2 | $0 (2022) |
| Xeris Pharmaceuticals, Inc. | $22.81 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80.69 | 3 | Radius Health, Inc. ($49.54) |
| 2023 | $78.01 | 4 | Abbott Laboratories ($41.45) |
| 2022 | $38.74 | 3 | Currax Pharmaceuticals LLC ($27.03) |
| 2020 | $284.13 | 3 | AstraZeneca Pharmaceuticals LP ($250.00) |
| 2019 | $8,165 | 12 | AstraZeneca Pharmaceuticals LP ($8,141) |
| 2018 | $8,576 | 18 | AstraZeneca Pharmaceuticals LP ($7,747) |
| 2017 | $7,328 | 10 | AstraZeneca Pharmaceuticals LP ($6,544) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Durable Pump | ||||||
| 08/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Obesity | ||||||
| 05/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $49.54 | General |
| Category: Endocrinology | ||||||
| 10/31/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Diabetes Care | ||||||
| 07/28/2023 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 07/07/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes Care | ||||||
| 07/06/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $13.75 | General |
| Category: non-opioid analgesic | ||||||
| 09/02/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Obesity | ||||||
| 06/16/2022 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Obesity | ||||||
| 06/08/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 10/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: DIABETES | ||||||
| 01/23/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 11/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $110.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Diabetes | ||||||
| 09/26/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Diabetes | ||||||
| 05/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $20.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 531 | 783 | $148,605 | $62,559 |
| 2022 | 4 | 517 | 788 | $145,345 | $59,977 |
| 2021 | 6 | 675 | 813 | $145,900 | $63,517 |
| 2020 | 6 | 701 | 935 | $145,990 | $63,634 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 457 | $91,400 | $37,930 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 224 | $31,360 | $13,320 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $22,275 | $9,552 | 42.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,570 | $1,757 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 455 | $91,000 | $37,863 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 261 | $36,540 | $14,816 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $14,575 | $5,911 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,230 | $1,387 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 211 | 302 | $60,010 | $27,561 | 45.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 237 | 280 | $38,875 | $16,360 | 42.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 85 | 85 | $23,375 | $10,373 | 44.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 46 | 49 | $9,320 | $3,714 | 39.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $6,460 | $2,976 | 46.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 58 | 59 | $7,860 | $2,533 | 32.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 298 | 491 | $83,500 | $34,860 | 41.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 209 | 247 | $28,480 | $12,121 | 42.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 68 | 68 | $18,700 | $7,110 | 38.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 53 | 55 | $6,600 | $4,843 | 73.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 47 | 48 | $4,290 | $2,788 | 65.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 26 | 26 | $4,420 | $1,911 | 43.2% |
About Dr. Mustapha Abdul-Rahman, MD
Dr. Mustapha Abdul-Rahman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588756886.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mustapha Abdul-Rahman, MD has received a total of $24,550 in payments from pharmaceutical and medical device companies, with $80.69 received in 2024. These payments were reported across 53 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,000).
As a Medicare-enrolled provider, Abdul-Rahman has provided services to 2,424 Medicare beneficiaries, totaling 3,319 services with total Medicare billing of $249,687. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Winchester, VA
- Active Since 09/28/2006
- Last Updated 02/11/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1588756886
Products in Payments
- FARXIGA (Drug) $19,388
- BYDUREON (Drug) $3,276
- t-slim insulin pump (Device) $1,550
- Tymlos (Drug) $49.54
- FREESTYLE LIBRE 3 (Device) $41.45
- INVOKANA (Drug) $27.54
- CONTRAVE (Drug) $27.03
- GVOKE PFS (Drug) $22.81
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $22.81
- Wegovy (Drug) $17.12
- Unithroid (Drug) $17.11
- SOLIQUA (Drug) $17.05
- MINIMED 780G (Device) $14.03
- LICART (Drug) $13.75
- Omnipod (Device) $12.67
- TRULICITY (Drug) $12.16
- Ozempic (Drug) $11.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Winchester
Nada Kerouz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,080
Dr. Daliha Aqbal, Md, Ms, MD, MS
Endocrinology, Diabetes & Metabolism — Payments: $268.81
Rileigh Provenza, Pharmd, PHARMD
Endocrinology, Diabetes & Metabolism